Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Invested Capital (2021 - 2025)

Senti Biosciences has reported Invested Capital over the past 5 years, most recently at $5.6 million for Q4 2025.

  • Quarterly results put Invested Capital at $5.6 million for Q4 2025, down 78.21% from a year ago — trailing twelve months through Dec 2025 was $5.6 million (down 78.21% YoY), and the annual figure for FY2025 was $5.6 million, down 78.21%.
  • Invested Capital for Q4 2025 was $5.6 million at Senti Biosciences, down from $8.1 million in the prior quarter.
  • Over the last five years, Invested Capital for SNTI hit a ceiling of $154.3 million in Q2 2022 and a floor of -$121.8 million in Q1 2022.
  • Median Invested Capital over the past 5 years was $31.8 million (2024), compared with a mean of $24.8 million.
  • Biggest five-year swings in Invested Capital: soared 270.2% in 2022 and later crashed 80.69% in 2024.
  • Senti Biosciences' Invested Capital stood at -$111.5 million in 2021, then skyrocketed by 214.18% to $127.3 million in 2022, then tumbled by 47.42% to $66.9 million in 2023, then plummeted by 61.67% to $25.6 million in 2024, then plummeted by 78.21% to $5.6 million in 2025.
  • The last three reported values for Invested Capital were $5.6 million (Q4 2025), $8.1 million (Q3 2025), and $24.7 million (Q2 2025) per Business Quant data.